Name: Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer by Morgans Financial Limited
Duration: 8 min 31 s
Description: Morgans analyst Iain Wilkie sat down with Leo Lee, CEO of ASX listed regenerative medicine player Regeneus (ASX:RGS). The two speak on its recent partnership deal for osteoarthritis in Japan and what it means for the company.

Money News

Money News | 047102023 Dianne Colledge, Private Client Advisor at Morgans

Morgans analyst Iain Wilkie sat down with Leo Lee, CEO of ASX listed regenerative medicine player Regeneus (ASX:RGS). The two speak on its recent partnership deal for osteoarthritis in Japan and what it means for the company.

Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer

Morgans is Australia's largest national full-service retail stockbroking and wealth management network with more than 240,000 client accounts, 500 authorised representatives and 950 employees operating from offices across all states and territories in Australia.

Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer

Morgans Financial Limited

Related tracks